Does self-regulation and autonomic regulation have an influence on survival in breast and colon carcinoma patients? results of a prospective outcome study

Health and Quality of Life Outcomes

Volumn 9, Issue , 2011, Pages

  Kröz, Matthias ^a,b,c   Reif, Marcus ^d   Büssing, Arndt ^e   Zerm, Roland ^a,b   Feder, Gene ^f   Bockelbrink, Angelina ^c   von Laue, Hans B ^g   Matthes H, Harald ^a,b   Willich, Stefan N ^c   Girke, Matthias ^a,b  

^a Research Institute Havelhöhe FIH   (Germany)

^b Charité CCM ^*  (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Institute for Clinical Research (IKF Berlin)   (Germany)

^e UNIVERSITY OF WITTEN HERDECKE   (Germany)

^f UNIVERSITY OF BRISTOL   (United Kingdom)

^g Humanus Institute   (Germany)

Author keywords

Autonomic regulation (ar); Breast cancer; Colorectal cancer; Coping; Self regulation (sr)

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; BREAST CARCINOMA; CANCER FATIGUE; CANCER SURVIVAL; CIRCADIAN RHYTHM; COLON CARCINOMA; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; ANXIETY DISORDER; AUTONOMIC NEUROPATHY; BREAST TUMOR; CASE CONTROL STUDY; CLINICAL TRIAL; COLON TUMOR; DEPRESSION; MIDDLE AGED; MULTICENTER STUDY; OBSERVATION; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; SURVIVAL RATE;

ANXIETY DISORDERS; AUTONOMIC NERVOUS SYSTEM DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SURVIVAL RATE;

EID: 80053376320     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-9-85     Document Type: Article

References (49)

1. Astradsson E, Granath L, Heedman PA, Starkhammar H. Cancer patients hospitalised for palliative reasons. Symptoms and needs presented at a university hospital. Support Care Cancer 2001, 9(2):97-102.
2. Goldstein D, Bennett B, Friedlander M, Davenport T, Hickie I, Lloyd A. Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer 2006, 6:240.
3. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000, 11(8):971-975.
4. Davidson JR, MacLean AW, Brundage MD, Schulze K. Sleep disturbance in cancer patients. Soc Sci Med 2002, 54(9):1309-1321.
5. Roscoe JA, Morrow GR, Hickok JT, Bushunow P, Matteson S, Rakita D, Andrews PL. Temporal interrelationships among fatigue, circadian rhythm and depression in breast cancer patients undergoing chemotherapy treatment. Support Care Cancer 2002, 10(4):329-336.
6. Mormont M, Waterhouse J. Contribution of the rest-activity circadian rhythm to quality of life in cancer patients. Chronobiol Internat 2002, 19(1):313-323.
7. Mormont MC, Waterhouse J, Bleuzen P, Giacchetti S, Jami A, Bogdan A, Lellouch J, Misset JL, Touitou Y, Levi F. Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 2000, 6(8):3038-3045.
8. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005, 30(1):92-100.
9. Kröz M, Feder G, von Laue H, Zerm R, Reif M, Girke M, Matthes H, Gutenbrunner C, Heckmann C. Validation of a questionnaire measuring the regulation of autonomic function. BMC Complement Altern Med 2008, 8:26.
10. Antonovsky A. Unraveling the mystery of health. How people manage stress and stay well. 1987, San Francisco, London: Jossey-Bass.
11. Grossarth-Maticek R. Systemische Epidemiologie und präventive Verhaltensmedizin chronischer Erkrankungen. 1999, Berlin, New York: Walter de Gruyter.
12. Gotay CC, Isaacs P, Pagano I. Quality of life in patients who survive a dire prognosis compared to control cancer survivors. Psychooncology 2004, 13(12):882-892.
13. Surtees PG, Wainwright NW, Luben R, Khaw KT, Day NE. Mastery, sense of coherence, and mortality: evidence of independent associations from the EPIC-Norfolk Prospective Cohort Study. Health Psychol 2006, 25(1):102-110.
14. Eysenck HJ. Cancer, personality and stress: prediction and prevention. Behav Res Ther 1994, 16:167-215.
15. Grossarth-Maticek R, Eysenck HJ. Self-regulation and mortality from cancer, coronary heart disease, and other causes: a prospective study. Person individ Diff 1995, 19(6):781-795.
16. Schumacher J, Wilz G, Gunzelmann T, Brahler E. The Antonovsky Sense of Coherence Scale Test statistical evaluation of a representative population sample and construction of a brief scale. Psychother Psychosom Med Psychol 2000, 50(12):472-482.
17. Eriksson M, Lindstrom B. Validity of Antonovsky's sense of coherence scale: a systematic review. J Epidemiol Community Health 2005, 59(6):460-466.
18. Schnyder U, Buchi S, Sensky T, Klaghofer R. Antonovsky's sense of coherence: trait or state?. Psychother Psychosom 2000, 69(6):296-302.
19. Grossarth-Maticek R, Kiene H, Baumgartner SM, Ziegler R. Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study. Altern Ther Health Med 2001, 7(3):57-66. 68-72, 74-56 passim.
20. Büssing A, Girke M, Heckmann C, Schad F, Ostermann T, Kröz M. Validation of the self regulation questionnaire as a measure of health in quality of life research. Eur J Med Res 2009, 14(5):223-227.
21. Herrmann C, Buss U. HADS-D, Hospital Anxiety and Depression Scale-Deutsche Version. Testdokumentation und Handanweisung. 1995, Bern, Göttingen, Toronto, Seattle: Verlag Hans Huber.
22. Karnofsky DA, Adelmann W, Craver F. The use of nitrogen mustard in the palliative treatment of carcinoma. Cancer 1948, 1:634-656.
23. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
24. Lin DY, Wei LJ, Ying Z. Checking the Cox Model with Cumulative Sums of Martingale-Based Residuals. Biometrika 1993, 80:557-572.
25. Kröz M, Schad F, Reif M, von Laue H, Feder G, Zerm R, Willich S, Girke M, Brinkhaus B. Validation of the State Version Questionnaire on Autonomic Regulation (State-aR) for Cancer Patients. Eur J Med Res 2011,
26. DeCoster V, Cummings S. Coping with type 2 diabetes: do race and gender matter?. Soc Work Health Care 2004, 40(2):37-53.
27. Frentzel-Beyme R, Grossarth-Maticek R. The interaction between risk factors and self-regulation in the development of chronic diseases. Int J Hyg Environ Health 2001, 204(1):81-88.
28. Kröz M, Büssing A, von Laue HB, Reif M, Feder G, Schad F, Girke M, Matthes H. Reliability and validity of a new scale on internal coherence (ICS) of cancer patients. Health Qual Life Outcomes 2009, 7:59.
29. Poppius E, Virkkunen H, Hakama M, Tenkanen L. The sense of coherence and incidence of cancer--role of follow-up time and age at baseline. J Psychosom Res 2006, 61(2):205-211.
30. Wainwright NW, Surtees PG, Welch AA, Luben RN, Khaw KT, Bingham SA. Sense of coherence, lifestyle choices and mortality. J Epidemiol Community Health 2008, 62(9):829-831.
31. Grossarth-Maticek R, Eysenck HJ. Creative novation behaviour therapy as a prophylactic treatment for cancer and coronary heart disease: Part I--Description of treatment. Behav Res Ther 1991, 29(1):1-16.
32. Grossarth-Maticek R, Eysenck H, Boyle G, Heeb J, Costa S, Diel I. Interaction of psychosocial and physical risk factors in the causation of mammary cancer, and its prevention through psychological methods of treatment. J Clin Psychol 2000, 56(1):33-50.
33. Ziegler R, Grossarth-Maticek R. Individual Patient Data Meta-analysis of Survival and Psychosomatic Self-regulation from Published Prospective Controlled Cohort Studies for Long-term Therapy of Breast Cancer Patients with a Mistletoe Preparation (Iscador). Evid Based Complement Alternat Med 2008, 11:11.
34. Grossarth-Maticek R, Ziegler R. Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis. Eur J Med Res 2006, 11(11):485-495.
35. Robert Koch Institut Krebs in Deutschland 2005/2006 Häufigkeiten und Trends. , http://www.rki.de/nn_196910/DE/Content/GBE/Gesundheitsberichterstattung/GBEDownloadsB/KID2010.html?__nnn=true
36. Wettergren L, Bjorkholm M, Axdorph U, Langius-Eklof A. Determinants of health-related quality of life in long-term survivors of Hodgkin's lymphoma. Qual Life Res 2004, 13(8):1369-1379.
37. Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, Giacchetti S, Coudert B, Iacobelli S, Genet D, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res 2009, 69(11):4700-4707.
38. Mustian KM, Morrow GR, Carroll JK, Figueroa-Moseley CD, Jean-Pierre P, Williams GC. Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue. Oncologist 2007, 12(Suppl 1):52-67.
39. Meyerhardt JA, Giovannucci EL, Holmes MD, Chan AT, Chan JA, Colditz GA, Fuchs CS. Physical activity and survival after colorectal cancer diagnosis. J Clin Oncol 2006, 24(22):3527-3534.
40. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. Jama 2005, 293(20):2479-2486.
41. Roscoe JA, Kaufman ME, Matteson-Rusby SE, Palesh OG, Ryan JL, Kohli S, Perlis ML, Morrow GR. Cancer-related fatigue and sleep disorders. Oncologist 2007, 12(Suppl 1):35-42.
42. Palesh OG, Roscoe JA, Mustian KM, Roth T, Savard J, Ancoli-Israel S, Heckler C, Purnell JQ, Janelsins MC, Morrow GR. Prevalence, demographics, and psychological associations of sleep disruption in patients with cancer: University of Rochester Cancer Center-Community Clinical Oncology Program. J Clin Oncol 2008, 28(2):292-298.
43. Fu L, Pelicano H, Liu J, Huang P, Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002, 111(1):41-50.
44. Filipski E, Li XM, Levi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control 2006, 17(4):509-514.
45. Savard J, Villa J, Ivers H, Simard S, Morin CM. Prevalence, natural course, and risk factors of insomnia comorbid with cancer over a 2-month period. J Clin Oncol 2009, 27(31):5233-5239.
46. Kramer JA, Curran D, Piccart M, de Haes JC, Bruning P, Klijn J, Van Hoorebeeck I, Paridaens R. Identification and interpretation of clinical and quality of life prognostic factors for survival and response to treatment in first-line chemotherapy in advanced breast cancer. Eur J Cancer 2000, 36(12):1498-1506.
47. Groenvold M, Petersen MA, Idler E, Bjorner JB, Fayers PM, Mouridsen HT. Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Res Treat 2007, 105(2):209-219.
48. Montazeri A. Quality of life data as prognostic indicators of survival in cancer patients: an overview of the literature from 1982 to 2008. Health Qual Life Outcomes 2009, 7:102.
49. Kröz M, Zerm R, Kuhnert N, Brauer D, Von Laue H, Bockelbrink A, Reif M, Schad F, Feder G, Heckmann C, et al. The influence of self- and autonomic regulation on cancer-related fatigue and distress in breast cancer and colorectal cancer patients - a prospective study. European Journal of Integrative Medicine 2009, 1(supplement):182.